Literature DB >> 15818439

Androgenetic alopecia and current methods of treatment.

Martina Bienová1, Renata Kucerová, Michala Fiurásková, Marián Hajdúch, Zdenìk Koláŕ.   

Abstract

Androgenetic alopecia (AGA) is a common dermatological condition affecting both men and women. In the case of men, up to 30% over the age of 30 and more than 50% over the age of 50 are affected. AGA also affects women although clinical signs are usually milder and associated with diffuse thinning of the scalp hair. AGA invariably causes serious psychological problems especially in women. By far the most promising approaches to the treatment of baldness in men are drug therapies, such as topical minoxidil and finasteride administered systemically. Mild to moderate AGA in women can be treated with antiandrogens and/or topical minoxidil with good results in many cases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15818439

Source DB:  PubMed          Journal:  Acta Dermatovenerol Alp Pannonica Adriat        ISSN: 1318-4458


  11 in total

Review 1.  Androgenetic alopecia: a review.

Authors:  Francesca Lolli; Francesco Pallotti; Alfredo Rossi; Maria C Fortuna; Gemma Caro; Andrea Lenzi; Andrea Sansone; Francesco Lombardo
Journal:  Endocrine       Date:  2017-03-28       Impact factor: 3.633

2.  YKL-40 A Sensitive Biomarker for Early Androgenetic Alopecia and Early Hidden Metabolic Syndrome.

Authors:  Doaa M Elhabak; Walid Abdel Abdel Halim
Journal:  Int J Trichology       Date:  2020-05-05

Review 3.  Interventions for female pattern hair loss.

Authors:  Esther J van Zuuren; Zbys Fedorowicz; Jan Schoones
Journal:  Cochrane Database Syst Rev       Date:  2016-05-26

4.  Scaffold-Assisted Artificial Hair Implantation in a Rat Model.

Authors:  Joshua K Au; Miguel Fernando Palma Diaz; Tara Aghaloo; Maie A St John
Journal:  JAMA Facial Plast Surg       Date:  2018-05-01       Impact factor: 4.611

5.  Finasteride induced depression: a prospective study.

Authors:  Babak Rahimi-Ardabili; Ramin Pourandarjani; Peiman Habibollahi; Amir Mualeki
Journal:  BMC Clin Pharmacol       Date:  2006-10-07

6.  Effect of Adiantum Capillus veneris Linn on an Animal Model of Testosterone-Induced Hair Loss.

Authors:  Maryam Noubarani; Hossein Rostamkhani; Mohammad Erfan; Mohammad Kamalinejad; Mohammad Reza Eskandari; Mohammad Babaeian; Jamshid Salamzadeh
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

7.  Outcome of Intra-operative Injected Platelet-rich Plasma Therapy During Follicular Unit Extraction Hair Transplant: A Prospective Randomised Study in Forty Patients.

Authors:  Suruchi Garg
Journal:  J Cutan Aesthet Surg       Date:  2016 Jul-Sep

8.  Understanding patient and physician perceptions of male androgenetic alopecia treatments in Asia-Pacific and Latin America.

Authors:  Zrinka Lulic; Shigeki Inui; Woo-Young Sim; Hoon Kang; Gwang Seong Choi; Woosung Hong; Toshiki Hatanaka; Timothy Wilson; Michael Manyak
Journal:  J Dermatol       Date:  2017-03-31       Impact factor: 4.005

Review 9.  Nanostructured Drug Delivery Systems for Targeting 5-α-Reductase Inhibitors to the Hair Follicle.

Authors:  Silvia Tampucci; Valentina Paganini; Susi Burgalassi; Patrizia Chetoni; Daniela Monti
Journal:  Pharmaceutics       Date:  2022-01-26       Impact factor: 6.321

10.  Low-level light therapy using a helmet-type device for the treatment of androgenetic alopecia: A 16-week, multicenter, randomized, double-blind, sham device-controlled trial.

Authors:  Jung Soo Yoon; Won Young Ku; Jang Hyun Lee; Hee Chang Ahn
Journal:  Medicine (Baltimore)       Date:  2020-07-17       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.